Leaders of the European Coalition Against Drugs, including the UK, gathered on 12 November 2026, to address drug-related issues across the continent. The coalition aims to protect nations from the harm caused by drugs, which is seen as endangering the rule of law, domestic security, and populations.
The coalition plans to operationalise its efforts with concrete initiatives, focusing on both prevention and reducing demand, alongside robust action against criminal networks. This includes exploring the establishment of a network of focal points involving port authorities, law enforcement, and the private sector to reinforce port and shipping security against drug trafficking.
Further actions include enhanced cooperation for at-sea interdictions of narcotics, particularly in the Gulf of Guinea, and a structured dialogue with countries willing to cooperate on this issue. The coalition also intends to fight illicit financial flows and money laundering, welcoming ongoing work by the European Union on a new sanction mechanism targeting criminal assets.
A significant concern highlighted is the surge in synthetic drug manufacturing and consumption, which poses a major public health threat. The coalition stresses the importance of rapid cross-border information sharing and coordinated responses to prevent overdose deaths, particularly from synthetic opioids like nitazenes and emerging orphines.
Additionally, the coalition seeks to promote a "catch-all" mechanism for customs authorities to investigate and seize substances presumed to be for unlawful use, even if not identified as drug precursors. Action will also be taken with Ukraine, focusing on prevention and combating trafficking, with support from the United Nations Office on Drugs and Crime (UNODC).